Matches in Wikidata for { <http://www.wikidata.org/entity/Q28678663> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q28678663 description "2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած" @default.
- Q28678663 description "2004 թվականի ապրիլին հրատարակված գիտական հոդված" @default.
- Q28678663 description "artículu científicu espublizáu en 2004" @default.
- Q28678663 description "im April 2004 veröffentlichter wissenschaftlicher Artikel" @default.
- Q28678663 description "scientific journal article" @default.
- Q28678663 description "vedecký článok (publikovaný 2004/04/01)" @default.
- Q28678663 description "vědecký článek publikovaný v roce 2004" @default.
- Q28678663 description "wetenschappelijk artikel (gepubliceerd op 2004/04/01)" @default.
- Q28678663 description "наукова стаття, опублікована у квітні 2004" @default.
- Q28678663 description "مقالة علمية (نشرت في أبريل 2004)" @default.
- Q28678663 name "Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects" @default.
- Q28678663 name "Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects" @default.
- Q28678663 name "Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects" @default.
- Q28678663 type Item @default.
- Q28678663 label "Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects" @default.
- Q28678663 label "Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects" @default.
- Q28678663 label "Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects" @default.
- Q28678663 prefLabel "Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects" @default.
- Q28678663 prefLabel "Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects" @default.
- Q28678663 prefLabel "Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects" @default.
- Q28678663 P1433 Q28678663-D9F3E5FF-8A41-49C2-BB38-5E2078AE1219 @default.
- Q28678663 P1476 Q28678663-BA032466-ECDB-4CC1-9552-2C02A628DEDC @default.
- Q28678663 P2093 Q28678663-0483A928-E473-4A21-A109-9B19EDC8FDCE @default.
- Q28678663 P2093 Q28678663-97B3A4C7-B193-473B-ADEC-643A382A6EF5 @default.
- Q28678663 P2093 Q28678663-C7642DB6-9556-4FA5-B98C-A20A0FAC3538 @default.
- Q28678663 P304 Q28678663-138226FD-3366-4B01-A9C5-11F15A96F4A2 @default.
- Q28678663 P31 Q28678663-40F27293-7998-4E1B-A781-8E5D2960A5C5 @default.
- Q28678663 P356 Q28678663-705B4943-34FB-491A-AD70-75EFFBFF8E05 @default.
- Q28678663 P407 Q28678663-29CEB353-F996-460F-B5C5-5E67D58A7782 @default.
- Q28678663 P433 Q28678663-093A2850-66BD-4313-B299-5D7725736098 @default.
- Q28678663 P478 Q28678663-FC77E95C-E773-418A-B960-E01A5609CAA2 @default.
- Q28678663 P50 Q28678663-C01AE145-31E9-43D9-B478-305F7AFBEBB0 @default.
- Q28678663 P577 Q28678663-0358C82D-163E-4603-B295-E7229F821261 @default.
- Q28678663 P698 Q28678663-BEA16C10-C554-4F75-9979-7BC7B0F51340 @default.
- Q28678663 P921 Q28678663-6FE373D8-9E2E-4A80-9074-2A98192A8465 @default.
- Q28678663 P921 Q28678663-F505CE98-6553-4BDD-949F-FF435E63324E @default.
- Q28678663 P356 0008-5472.CAN-03-3106 @default.
- Q28678663 P698 15059917 @default.
- Q28678663 P1433 Q326097 @default.
- Q28678663 P1476 "Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects" @default.
- Q28678663 P2093 "Mark X Sliwkowski" @default.
- Q28678663 P2093 "Michael G Brattain" @default.
- Q28678663 P2093 "Patricia St Clair" @default.
- Q28678663 P304 "2601-2609" @default.
- Q28678663 P31 Q13442814 @default.
- Q28678663 P356 "10.1158/0008-5472.CAN-03-3106" @default.
- Q28678663 P407 Q1860 @default.
- Q28678663 P433 "7" @default.
- Q28678663 P478 "64" @default.
- Q28678663 P50 Q55873508 @default.
- Q28678663 P577 "2004-04-01T00:00:00Z" @default.
- Q28678663 P698 "15059917" @default.
- Q28678663 P921 Q422248 @default.
- Q28678663 P921 Q79460 @default.